Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Unknown 2Active not recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 24Carcinoma, Intraductal, Noninfiltrating 3Breast Cancer Female 2Premenopausal Breast Cancer 1Polycystic Ovary Syndrome 1Ovarian Neoplasms 1Neoplasms 1Neoplasm Recurrence, Local 1Infertility 1Hot Flashes 1Carcinoma, Lobular 1Breast Neoplasms, Male 1Breast Carcinoma In Situ 1Breast Cancer Subjects 1Anovulation 1

Interventions

Tamoxifen 2pyrotinib 1exemestane 1abemaciclib 1Surgical Procedures, Operative 1Radiotherapy 1Radiation Dose Hypofractionation 1Mammaplasty 1Letrozole 1Drug Therapy 1Aromatase Inhibitors 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Breast Cancer Female × Tamoxifen × Clear all
NCT04584853 2026-01-14

POETIC-A

Institute of Cancer Research, United Kingdom

Phase 3 Active not recruiting
123 enrolled
Breast

Breast Cancer Female

NCT03917082 2023-06-15

LALEAST

British Columbia Cancer Agency

Phase 2 Active not recruiting
290 enrolled
Breast

Breast Cancer Female

Data powered by HemOnc (CC BY 4.0) Colophon âš¡